Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
128 Cards in this Set
- Front
- Back
Name a folic acid analog
|
Methotrexate
|
|
Name 3 purine analogs
|
1. 6-mercaptopurine
2. 6-thioguanine 3. fludarabine |
|
6-mercaptopurine is what kind of antimetabolite?
|
purine analog
|
|
6-thioguanine is what kind of antimetabolite?
|
purine analog
|
|
fludarabine is what kind of antimetabolite?
|
purine analog
|
|
Methotrexate is what kind of antimetabolite?
|
Folic acid analog
|
|
Name 3 pyrimidine analogs
|
1. 5-Fluorouracil
2. Cytosine arabinoside (ara-c) 3. gemcitabine |
|
5-fluorouracil is what kind of antimetabolite?
|
pyrimidine analog
|
|
cytosine arabinoside (ara-c) is what kind of antimetabolite?
|
pyrimidine analog
|
|
gemcitabine is what kind of antimetabolite?
|
pyrimidine analog
|
|
What is the function of hydoxyurea
|
Inhibit ribonucleotide reductase
|
|
What antimetabolite inhibits ribonucleotide reductase?
|
Hydroxyurea
|
|
Folic acid analogs, purine analogs, pyrimidine analogs, and hydroxyurea all act as what class of anti-cancer drugs?
|
Antimetabolites
|
|
Premetrexed is used to treat what kind of cancer?
|
Mesothelioma
|
|
Are antimetabolites active as given?
|
No, must be activated intracellularly
|
|
Antimetabolites do/do not have structural similarity to physiological intermediates?
|
Do have structural similarity to physiological intermediates
|
|
What is the main mechanism of action of antimetabolites?
|
Inhibit de novo synthesis of purine and pyrimidines (nucleotides)
|
|
What two antimetabolites inhibit phophoribosyl pyrophosphate (PRPP) amidotransferase?
|
1. 6-mercaptopurine
2. 6-thioguanine |
|
What enzyme is required for generation of purine ring?
|
Dihydrofolate reductase (DHFR)
|
|
What two antimetabolites inhibit DHFR?
|
1. MTX (Methotrexate)
2. Trimetrexate (TMQ) |
|
IMP gets converted to what two possibilites?
|
1. GMP
2. AMP These are purines (Adenine and guanine) |
|
What drug inhibits the conversion of IMP to AMP and GMP
|
6-mercaptopurine
|
|
What enzyme is responsible for conversion of IMP --> AMP, GMP?
|
IMP dehydrogenase
|
|
What drug is most selective against the IMP dehydrogenase enzyme?
|
6-TG
|
|
What two other drugs besides 6-TG inhibit IMP dehydrogenase preventing IMP --> AMP, GMP?
|
6-MP and tiazofurin
|
|
What enzyme converts ADP, GDP --> dADP, dGDP?
|
Ribonucleotide reductase
|
|
What two drugs inhibit ribonucleotide reductase?
|
Hydroxyurea and fludarabine (purine analog)
|
|
Which is more lipid soluble (MTX or TMQ)?
|
TMQ = trimetrexate
|
|
Which antifolate is multitargeted? (MTX, TMQ, or pemetrexed)
|
Pemetrexed
|
|
What is an essential dietary factor required for synthesis of DNA precursors (thymidylate and purines) and RNA (purines)?
|
Folic acid
|
|
For which drug is the primary mechanism of action inhibition of DHFR?
|
Methotrexate (MTX)
|
|
Which drug depletes THF cofactors required for synthesis of thymidylate and purines?
|
Methotrexate (MTX)
|
|
Does MTX require a specific transporter to enter the cell? If so, which one?
|
Yes - Reduced folate transporter
|
|
Polyglutamation is a conversion that occurs. This does/does not inhibit other folate-requiring enzymes for thymidylate and purine synthesis?
|
Does inhibit other folate-requiring enzymes for thymidylate and purine synthesis
|
|
Polyglutamation increases/decreases the affinity of MTX for thymidylate synthetase
|
Increases the affiinity of MTX for thymidylate synthetase
|
|
Polyglutamation allows/prevents egress of MTX from the cell?
|
Prevents egress of MTX from the cell
|
|
Is a transport protein required for TMQ (trimetrexate)?
|
No - TMQ is more lipid soluble and does not need a transport protein
|
|
Does MTX require a transport protein
|
Yes MTX requires a transport protein
|
|
If you encounter a patient with folate transport protein deficient resistant cancer, which folate analog should be given?
|
Trimetrexate (TMQ) because it is more lipid soluble and does not need a transport protein
|
|
MTX also activates p53, cell cycle arrest and apoptosis (T/F)
|
True
|
|
Why is leucovorin given to patient on MTX?
|
To alleviate BM suppression
|
|
5-formyl-tetrahydrofolate is also known as what trade name?
|
Leucovorin
|
|
What drug can rescue the cell from MTX cytotoxicity?
|
Leucovorin (5-formyl-tetrahydrofolate)
|
|
Is MTX toxic to all rapidly dividing cells?
|
Yes, MTX is toxic to all rapidly dividing cells
|
|
MTX kills cells in which phase of the cell cycle?
|
S phase
|
|
MTX is more effective in slower/more rapid proliferating tumors?
|
Rapidly proliferating tumors
|
|
Coadministered drugs that displace MTX from serum albumin can increase/decrease toxicity?
|
Increase toxicity
ASA and penicillins. Probenecid blocks organic acid transport = interfere also |
|
ASA, sulfonamides, and penicillins are protein bound and can have what effect when given with MTX?
|
Displace MTX from serum albumin and increase MTX toxicity
|
|
Ascites and pleural effusions are/are not contraindications to MTX?
|
Are contraindications. MTX can leak out b/c it gains access to third space
|
|
MTX is metabolized by liver or kidney?
|
Kidney, as salt of weak acid
ASA and penicillin also excreted this way - can interfere Probenecid blocks organic acid transport system - interferes |
|
What is the main toxicity associated with MTX?
|
Myelosuppression
|
|
What drug is used to treat ALL in children?
|
MTX
|
|
What drug is used in high-dose as adjuvant to treat osteogenic sarcoma?
|
MTX
|
|
What drug is also used to treat psoriasis, rheumatoid arthritis, and for immunosuppression?
|
MTX
|
|
Which purine analog is the analog of hypoxanthine?
|
6-mercaptopurine
|
|
Which purine analog is the analog of guanine?
|
6-thioguanine
|
|
Nucleotides form from 6-MP and 6-TG inhibits de novo purine synthesis (inhibits PRPP amidoTFase) and does/does not become incorporated into nucleic acids?
|
Does also become incorporated into nucleic acids
|
|
6-MP and 6-TG + PRPP are catalyzed by what enzyme?
|
HGPRT (hypoxanthine-guanine phosphoribosyltransferase)
|
|
T-IMP and 6-thioGMP can/cannot be incorporated into DNA
|
Can be incorporated into DNA
|
|
T-IMP and 6-thioGMP are formed from what enzyme?
|
HGPRT (hypoxanthine guanine phosphoribosyl transferase)
|
|
T-IMP is a good/poor substrate for guanylyl kinase?
|
T-IMP is a poor substrate for guanylyl kinase. Leads to accumulation of T-IMP accumulation in cells and negative feedback inhibition of PRPP amidotransferase (first step in de novo synthesis)
|
|
What enzyme is involved in the first step of de novo purine synthesis?
|
PRPP amidotransferase
|
|
T-IMP accumulation results in what effect of PRPP amidotransferase?
|
Negative feedback inhibition of PRPP amidotransferase (first step in de novo synthesis)
|
|
Negative feedback inhibition of PRPP amidotransferase caused by accumulation of T-IMP is the most important effect for what drug?
|
6-mercaptopurine
|
|
Tumor cell lysis syndrome can occur when given 6-MP. What drug can be given to alleviate this?
|
Allopurinol (xanthine oxidase inhibitor)
|
|
If you give a patient allopurinol (xanthine oxidase inhibitor) what adjustment must be made to the oral dose of 6-MP?
|
Reduce the oral dose b 75% to decrease the risk of toxicity
|
|
Elimination of 6-MP and 6-TG is renal or hepatic?
|
Hepatic b/c orally active (PO) and 6-MP is extensively metabolized by Xanthine Oxidase
This can lead to hyperuricemia (Tumor Lysis syndrome) Prevent with Allopurinol (XO inhibitor) + reduced dose of 6-MP by 75% |
|
If there is increased activity of MRP5, what happens to the drug?
|
Increased efflux of the drug = resistance to the drug
|
|
The active triphosphate form of fludarabine inhibits DNA Pol alpha, ribonucleotide reductase, DNA primase, and DNA ligase resulting in inhibition of what?
|
DNA and RNA synthesis
|
|
If active triphosphate form of fludarabine is incorporated into DNA, what happens?
|
Chain termination
|
|
Active triphosphate form of fludarabine inhibits RNA processing and mRNA translation (T/F)
|
True
|
|
For which purine metabolite is the major effect through the activation of apoptosis?
|
Fludarabine
|
|
Fludarabine is available PO or IV?
|
IV
|
|
6-MP and 6-TG are usually given PO or IV?
|
PO
|
|
Renal clearance represents how much % of total body clearance?
|
40%
|
|
What is the main toxicity associated with fludarabine?
|
Myelosuppression
|
|
Which drug is mainly used for treatment of CLL?
|
Fludarabine (converted to active triphosphate form intracellularly)
|
|
What enzyme phosphorylates fludarabine to give active triphosphate form of fludarabine?
|
deoxycytidine kinase
|
|
What is the most frequently targeted step in treatment with pyrimidine analog?
|
Conversion of dUMP to TMP
|
|
Name a unique substrate for DNA synthesis
|
TMP
|
|
What enzyme catalyzes the conversion of dUMP to TMP?
|
thymidylate synthase
|
|
What enzyme does 5-fluorouracil and FUdR inhibit?
|
thymidylate synthase
|
|
Reduced production of TTP causes enhanced incorporation of what into DNA?
|
dUTP
|
|
Conversion of UDP and CDP to dUDP and dCDP is catalyzed by what enzyme?
|
Ribonucleotide reductase (which is inhibited by Hydroxyurea)
|
|
What drug inhibits the incorporation of dCTP into DNA by DNA polymerase?
|
Ara-C
|
|
What drug is important for the treatment of colon cancer?
|
5-FU
|
|
What drug mimics uracil biochemically?
|
5-FU
|
|
Do you need THF for FdUMP to bind tightly to thymidylate synthetase?
|
yes, THF is needed
|
|
What is the metabolism of 5-FU?
|
Liver
|
|
What is the route of administration of 5-FU?
|
IV
|
|
Long continuous infusions or rapid IV injections of 5-FU are better?
|
Long continuous infusions
|
|
FUdR is administered directly into the liver via infusion pump to treat what cancer and metastasis?
|
Colon cancer and liver metastasis
|
|
What drug is used to treat liver mets from colon cancer?
|
FUdR
|
|
What enzyme is found in the liver that inactivates 5-FU
|
dihydropyrimidine dehydrogenase
|
|
Why is leucovorin given with 5-FU?
|
To enhance cytotoxicity
|
|
If cancer cells have insufficient levels of 5-10 methylene tetrahydrofolate, what drug can be give with 5-FU to enhance cytotoxicity?
|
Leucovorin
|
|
Gi toxicity, myelosuppression, skin hyperpigmentation and rashes are adverse reactions of what drug?
|
5-FU
|
|
What can be given along with 5-FU to lessen adverse side effects?
|
Pyridoxine (Vitamin B6)
|
|
Is 5-FU a radiation sensitizer?
|
Yes it is
|
|
Cytosine arabinoside is also known by what name?
|
Ara-C
|
|
What is the most important antimetabolite used in AML therapy?
|
Ara-C (cytosine arabinoside)
|
|
What is the most effective agent for induction of remission of AML?
|
Ara-C (cytosine arabinoside)
|
|
What anti-metabolite is incorporated into DNA and inhibits template function and chain elongation?
|
Ara-C
|
|
What drug inhibits DNA polymerase
|
Ara-C
Fludarabine (-)s DNA Pol alpha |
|
Cells not in S phase will/will not be affected by Ara-C
|
Will not be affected by Ara-C
|
|
There are high levels of cytdine deaminase in GI mucosa. How does this affect the route of administration of Ara-C?
|
Must be given IV
|
|
Increased synthesis and retention of Ara-CTP is associated with longer/shorter duration of complete remission in AML?
|
Longer duration of remission of AML
|
|
What is the difluoro analog of deoxycytidine?
|
Gemcitabine
|
|
Is the diphosphate form of gemcitabine active?
|
Yes both di and triphosphate forms of gemcitabine are active
|
|
What enzyme does dFdCDP inhibit?
|
dFdCDP inhibits ribonucleotide reductase --> depletion of pool of deoxynucleotides (dNTP)
|
|
Incorporation of gemcitabine nucleotides into DNA leads to what?
|
Strand termination
|
|
Can gemcitabine enhance its own activity?
|
Yes. Inhibits dCMP deaminase and prolongs the cellular halflife of active dFdCTP - explains the good activity of Gemcitabine in solid tumors
|
|
What drug has good activity in solid tumors?
|
Gemcitabine.
dFdCTP-mediated inhibition of dCMP deaminase = prolong cellular T1/2 of active dFdCTP = explains good activity of Gemcitabine in solid tumors |
|
What is the major toxicity of gemcitabine?
|
Myelosuppression
|
|
Gemcitabine is a radiosensitizer (T/F)
|
True. Do not use w/ radiation
|
|
Gemcitabine should/should not be used with radiotherapy?
|
Should not - it is a potent radiosensitizer
|
|
Hydroxyurea causes cell cycle arrest at what junction of the cell cycle?
|
G1/S phase boundary
|
|
What enzyme deoxifies ribonucleotides
|
ribonucleotide reductase
|
|
HU does/does not have synergistic toxicity with irradiation?
|
Does have synergistic effects - cells more sensitive to irradiation
|
|
What antimetabolite has the least myelosuppresion?
|
Hydroxyurea
|
|
hRRM2 subunit of ribonucleoside diphosphate reductase can be regenerated to restore enzyme activity T/F?
|
True - resistance to Hydroxyurea mechanism
|
|
6-MP + PRPP catalyzed by HGPRT gives what product?
|
T-IMP
|
|
6-TG + PRPP catalyzed by HGPRT gives what product
|
6-thioGMP
|
|
Between T-IMP and 6-thioGMP, which is the more prevalent product?
|
6-thioGMP
|
|
More 6-thioGMP or T-IMP is converted and incorporated into RNA and DNA?
|
6-thioGMP
|
|
Instead of being incorporated into DNA, 6-MP + PRPP catalyzed by HGPRT forms T-IMP which has what function?
|
Accumulates in cells leading to feedback inhibition of PRPP amidoTFase (first step in de novo synthesis)
|
|
What is the first step in de novo purine synthesis?
|
PRPP amidoTFase
|
|
T-IMP is a good/poor substrate for guanylyl kinase?
|
Poor substrate for guanylyl kinase
|